MDS-567 Real-world analysis of a large electronic medical record database of patients with higher-risk myelodysplastic neoplasms (HR MDS): Treatment profiles, clinical effectiveness, and key adverse event rates

2023
Shah R, Thanataveerat A, Rudraraju R, Curtis K, Jhaveri TZ, Askin G, Irwin DE, Pierzynski J, Hogea C, Sabate EJ, Sali AP, Williamson M
Read more